Anvisa To Access US FDA-Reviewed Data For More Robust Evaluations In Brazil

Brazil has also published its recent regulatory reliance regulations in English, a move designed to increase confidence in its decisions as it presses on with aligning its national practices with global best practices.

Brazil and US
Brazil and US Regulators Sign agreement to share information • Source: Shutterstock

Brazilian and US regulators, Anvisa and the Food and Drug Administration respectively, have signed an agreement to allow the two agencies to share commercially confidential and non-public information about medicines.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Product Reviews

More from Pink Sheet